The ANOMBRAL brand, founded in 2013 (Japan), from 440 sister brands and 4958 competing brands. The ANOMBRAL brand is owned by Takeda Pharmaceutical, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is JP3463000004. ANOMBRAL belongs to the Drug Manufacturers business sector.